“囤猴”业绩赚翻 “猴茅”股价齐涨

第一财经
Jul 15

7月17日上午,昭衍新药A股股价盘中涨停,港股股价大涨超过10%。得益于实验猴市场价格上涨叠加自身自然生长增值带来公允价值正向变动,昭衍新药预计2026年1-6月实现归属于上市公司股东的净利润约6亿元至9亿元,同比增加约8.85倍至13.77倍。昭衍新药的股价大涨也带动其他“猴茅”们股价上涨,其中康龙化成A股以及港股盘中股价大涨超过8%,药明康德A股以及港股股价也大涨超过4%。(第一财经记者林志吟...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10